Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced positive topline data from its Phase 2 AMPLIFY ...

Imagine wading through severe depression for years, taking medication after medication, with no relief. Now, envision discovering that what you were facing was not major depression but bipolar ...

Moments after Jenna Carberg gave birth to her daughter, doctors put the baby on her chest. “I felt a disconnect right away,” ...

Researchers say a single intravenous ketamine infusion can rapidly relieve severe depression and suicidal thoughts when ...

Researchers have found preliminary evidence that combining the hallucinogenic compound psilocybin with cognitive behavioral ...

Light therapy is linked to reduced symptoms of depression and improved sleep quality in patients with neuropsychiatric ...

Pediatric patients with neurodevelopmental disorders experience a substantially increased risk for co-occurring psychiatric conditions.

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Mental health professionals use the DSM to standardize the diagnosis and treatment processes for mental health conditions, including types of depression. The Diagnostic and Statistical Manual of ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...